Novo Nordisk | Kontanter Og Tilsvarende



Cash And Equivalent Endring Dato
ANI Pharmaceuticals USD 144.86M 121K 2024-12
Aurora Cannabis CAD 108.71M 23.79M 2024-12
Bausch Health Companies USD 1.13B 47M 2025-03
Bristol-Myers Squibb USD 10.88B 529M 2025-03
Canopy Growth CAD 16.31M 69.8M 2024-12
Corcept Therapeutics USD 127.66M 9.62M 2024-12
Drreddys Laboratories INR 1.1B 743M 2024-12
Eli Lilly USD 3.09B 175.1M 2025-03
GlaxoSmithKline GBP 4.46B 594M 2025-03
Merck USD 8.63B 4.61B 2025-03
Novartis USD 8.87B 4.74B 2024-12
Novo Nordisk 57.02B 4.2B 2024-09
Pacira USD 276.77M 30.81M 2024-12
Perrigo USD 409.9M 148.9M 2025-03
Prestige Brands USD 50.87M 666K 2024-12
Sanofi 7.99B 550M 2025-03
Supernus Pharmaceuticals USD 69.33M 37.66M 2024-12
Zoetis USD 1.72B 264M 2025-03



Novo Nordisk Kontanter Og Tilsvarende - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.